These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 14999228

  • 41. Transcriptional control of the B3GALT5 gene by a retroviral promoter and methylation of distant regulatory elements.
    Zulueta A, Caretti A, Signorelli P, Dall'olio F, Trinchera M.
    FASEB J; 2014 Feb; 28(2):946-55. PubMed ID: 24128890
    [Abstract] [Full Text] [Related]

  • 42. Evidence that the mouse 3' kappa light chain enhancer confers position-independent transgene expression in T- and B-lineage cells.
    Xu L, Tsuji K, Mostowski H, Candotti F, Rosenberg A.
    Hum Gene Ther; 2003 Dec 10; 14(18):1753-64. PubMed ID: 14670126
    [Abstract] [Full Text] [Related]

  • 43. A self-inactivating gamma-retroviral vector reduces manifestations of mucopolysaccharidosis I in mice.
    Metcalf JA, Ma X, Linders B, Wu S, Schambach A, Ohlemiller KK, Kovacs A, Bigg M, He L, Tollefsen DM, Ponder KP.
    Mol Ther; 2010 Feb 10; 18(2):334-42. PubMed ID: 19844196
    [Abstract] [Full Text] [Related]

  • 44. Durable and stratum-specific gene expression in epidermis.
    Ghazizadeh S, Doumeng C, Taichman LB.
    Gene Ther; 2002 Oct 10; 9(19):1278-85. PubMed ID: 12224010
    [Abstract] [Full Text] [Related]

  • 45. Increased functional expression of transgene in primary human lymphocytes using retroviral vectors modified with IRES and splicing motifs.
    Royal RE, Kershaw MH, Reeves ME, Wang G, Daly T, Treisman J, Lam J, Hwu P.
    Gene Ther; 2002 Aug 10; 9(16):1085-92. PubMed ID: 12140736
    [Abstract] [Full Text] [Related]

  • 46. Retroviral vector performance in defined chromosomal Loci of modular packaging cell lines.
    Gama-Norton L, Herrmann S, Schucht R, Coroadinha AS, Löw R, Alves PM, Bartholomae CC, Schmidt M, Baum C, Schambach A, Hauser H, Wirth D.
    Hum Gene Ther; 2010 Aug 10; 21(8):979-91. PubMed ID: 20222806
    [Abstract] [Full Text] [Related]

  • 47. Evaluation of retroviral vector design in defined chromosomal loci by Flp-mediated cassette replacement.
    Verhoeyen E, Hauser H, Wirth D.
    Hum Gene Ther; 2001 May 20; 12(8):933-44. PubMed ID: 11387058
    [Abstract] [Full Text] [Related]

  • 48. Self-inactivating alpharetroviral vectors with a split-packaging design.
    Suerth JD, Maetzig T, Galla M, Baum C, Schambach A.
    J Virol; 2010 Jul 20; 84(13):6626-35. PubMed ID: 20410274
    [Abstract] [Full Text] [Related]

  • 49. Functional characterization of a piscine retroviral promoter.
    Zhang Z, Kim E, Martineau D.
    J Gen Virol; 1999 Dec 20; 80 ( Pt 12)():3065-3072. PubMed ID: 10567636
    [Abstract] [Full Text] [Related]

  • 50. Suppression of tumor growth by viral vector-mediated gene transfer of N-terminal truncated platelet factor 4.
    Li Y, Jin Y, Chen H, Jie G, Tobelem G, Caen JP, Han ZC.
    Cancer Biother Radiopharm; 2003 Oct 20; 18(5):829-40. PubMed ID: 14629831
    [Abstract] [Full Text] [Related]

  • 51. A potential approach for gene therapy targeting hepatoma using a liver-specific promoter on a retroviral vector.
    Kuriyama S, Yoshikawa M, Ishizaka S, Tsujii T, Ikenaka K, Kagawa T, Morita N, Mikoshiba K.
    Cell Struct Funct; 1991 Dec 20; 16(6):503-10. PubMed ID: 1813147
    [Abstract] [Full Text] [Related]

  • 52. Transgene expression in the mouse cerebellar Purkinje cells with a minimal level of integration using long terminal repeat-modified lentiviral vectors.
    Takayama K, Torashima T.
    J Neurovirol; 2009 Sep 20; 15(5-6):371-9. PubMed ID: 19739019
    [Abstract] [Full Text] [Related]

  • 53. Self-inactivating retroviral vectors designed for transfer of whole genes into mammalian cells.
    Yu SF, von Rüden T, Kantoff PW, Garber C, Seiberg M, Rüther U, Anderson WF, Wagner EF, Gilboa E.
    Proc Natl Acad Sci U S A; 1986 May 20; 83(10):3194-8. PubMed ID: 3458176
    [Abstract] [Full Text] [Related]

  • 54. Functional analysis of the endogenous retroviral promoter of the human endothelin B receptor gene.
    Landry JR, Mager DL.
    J Virol; 2003 Jul 20; 77(13):7459-66. PubMed ID: 12805445
    [Abstract] [Full Text] [Related]

  • 55. Cell-culture assays reveal the importance of retroviral vector design for insertional genotoxicity.
    Modlich U, Bohne J, Schmidt M, von Kalle C, Knöss S, Schambach A, Baum C.
    Blood; 2006 Oct 15; 108(8):2545-53. PubMed ID: 16825499
    [Abstract] [Full Text] [Related]

  • 56. Transcriptional activity of the CD45 gene promoter in retroviral vector constructs.
    Anson DS, Occhiodoro T.
    Biochim Biophys Acta; 1994 Sep 13; 1219(1):81-8. PubMed ID: 8086481
    [Abstract] [Full Text] [Related]

  • 57. Template switching by RNA polymerase II in vivo. Evidence and implications from a retroviral system.
    Kandel ES, Nudler E.
    Mol Cell; 2002 Dec 13; 10(6):1495-502. PubMed ID: 12504023
    [Abstract] [Full Text] [Related]

  • 58. A new family of murine retroviral vectors with extended multiple cloning sites for gene insertion.
    Faustinella F, Kwon H, Serrano F, Belmont JW, Caskey CT, Aguilar-Cordova E.
    Hum Gene Ther; 1994 Mar 13; 5(3):307-12. PubMed ID: 8018745
    [Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.